Report #2830003

Received Mar 6, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 65 yrs
State: CA
Recovered: Not recovered
Vaccinated: Mar 3, 2025
Onset: Mar 4, 2025
Days to onset: 1
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	LA

Symptoms (1)

Lip blister

Symptom narrative

Blister lip; This non-serious case was reported by a consumer via call center representative and described the occurrence of lip blister in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concurrent medical conditions included anxiety. Concomitant products included fluoxetine hydrochloride (Prozac). On 03-MAR-2025 15:00, the patient received the 1st dose of Shingrix (left arm) .5 ml. On 04-MAR-2025, 1 days after receiving Shingrix, the patient experienced lip blister (Verbatim: Blister lip). The outcome of the lip blister was not resolved. It was unknown if the reporter considered the lip blister to be related to Shingrix. It was unknown if the company considered the lip blister to be related to Shingrix. Additional Information: GSK Receipt Date: 04-MAR-2025 The patient received Shingrix vaccine and 18 hours later she woke up with a blister on her lower lip. The reporter did not know the lot number of the vaccine.

Current illness

Anxiety

Other medications

PROZAC